10-K: Centene Reports $3.3 Billion Net Earnings for 2024, Navigating Medicaid Redeterminations and Medicare Changes

Centene Corporation announces a 6% increase in total revenues to $163.1 billion and net earnings of $3.3 billion for the year ended December 31, 2024, while managing Medicaid redeterminations and preparing for Medicare Part D changes.

Summary

• Centene Corporation's total revenues for 2024 reached $163.1 billion, a 6% increase compared to the previous year.
• Net earnings attributable to Centene were $3.3 billion, up from $2.7 billion in 2023.
• The company's membership totaled 28.6 million as of December 31, 2024, reflecting a 4% increase year-over-year.
• Medicaid membership stood at 13 million, while Marketplace membership reached 4.4 million.
• Medicare Advantage membership was 1.1 million, and Medicare PDP membership was 6.9 million.
• The Health Benefits Ratio (HBR) was 88.3%, compared to 87.7% in the prior year.
• The Selling, General, and Administrative (SG&A) expense ratio was 8.5%, a decrease from 9.0% in 2023.
• Operating cash flow was $154 million, a significant decrease from $8.1 billion in 2023, primarily due to changes in pharmacy receivables and risk adjustment payables.
• The company is navigating Medicaid redeterminations and preparing for significant changes to Medicare PDPs under the Inflation Reduction Act (IRA).
• Centene is focused on strategic decisions and investments to create additional value and position the organization for long-term strength, profitability, growth, and innovation.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While revenue and earnings increased, there are concerns about rising medical costs, declining cash flow, and regulatory challenges. The outlook is cautiously optimistic.

Positives

• Total revenues increased by 6% to $163.1 billion.
• Net earnings attributable to Centene rose to $3.3 billion.
• Membership increased by 4% to 28.6 million.
• The SG&A expense ratio decreased to 8.5% from 9.0% in 2023.
• Marketplace membership increased 12% year-over-year.
• Medicare PDP membership increased 50% year-over-year.
• Adjusted diluted EPS increased 7% year-over-year to $7.17.

Negatives

• Operating cash flow decreased significantly to $154 million from $8.1 billion in 2023.
• The HBR increased to 88.3% from 87.7% in 2023.
• Medicare Advantage membership declined 13% year-over-year.
• Medicaid membership decreased due to redeterminations.

Risks

• Medicaid redeterminations are impacting membership and HBR.
• Changes to Medicare Advantage pricing components may affect profitability.
• The IRA is expected to substantially increase PDP's risk exposure in 2025.
• Failure to maintain or improve quality Star ratings could negatively impact Medicare revenue.
• Cybersecurity threats and data security incidents could have a material adverse effect on the business.
• The expiration of the enhanced advance premium tax credit for Marketplace members could materially and adversely affect the business.

Future Outlook

Centene expects to navigate industry changes to benefit members, customers, providers, and shareholders, focusing on data and analytics to improve the provider and member experience. The company anticipates impacts from Medicaid redeterminations, Medicare Advantage Star ratings, and the implementation of the IRA.

Management Comments

• Centene is focused on strategic decisions and investments to create additional value and position the organization for long-term strength, profitability, growth, and innovation.
• Centene treats the whole person, an approach that is delivered locally and backed by the scale of Centene's expertise, data and resources.

Industry Context

Centene operates in a highly competitive environment subject to ongoing significant changes, including business consolidations, new strategic alliances, market pressures, and regulatory and legislative reform at the federal and state level. The company is adapting to the evolving healthcare landscape, including the ACA, Medicaid expansion, and Medicare Advantage programs.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or comparable companies.
• The document does not provide specific details on global benchmarks or comparable projects.

Legal Proceedings

• The Company is routinely subjected to legal and regulatory proceedings in the normal course of business.
• These matters can include, without limitation, periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, which could result in litigation.

Stakeholder Impact

• Shareholders: Impacted by financial performance, stock repurchases, and strategic decisions.
• Members: Affected by access to care, quality of services, and changes in government programs.
• Providers: Impacted by contract terms, reimbursement rates, and value-based arrangements.
• Employees: Influenced by compensation, benefits, and the company's culture.

Next Steps

• Continue to work with state partners to match rates to acuity post-redeterminations.
• Navigate evolving regulations related to Medicare and Medicaid.
• Implement strategies to improve Medicare Star ratings.
• Focus on data and analytics to improve the provider and member experience.
• Continue to target initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities.

Key Dates

Keywords

Centene, Medicaid, Medicare, Marketplace, HBR, Membership, Revenues, Earnings, Redeterminations, IRA, Star Ratings, Cybersecurity